导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 52.82% | 48/1050 |
| 近一周 | -0.52% | 508/1104 |
| 近一月 | -5.12% | 467/1103 |
| 近一季 | -16.21% | 836/1094 |
| 近半年 | 45.87% | 47/1074 |
| 近一年 | 72.47% | 27/1020 |
| 近两年 | 284.16% | 22/926 |
| 近三年 | 271.15% | 7/834 |
| 成立以来 | 377.91% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.83% 149/1070 |
81.94% 99/1101 |
- - |
- - |
| 2025 | 91.53% 20/1065 |
-1.28% 876/1014 |
6.70% 204/1038 |
62.34% 28/1050 |
12.01% 33/1065 |
| 2024 | 32.15% 15/1011 |
4.67% 114/960 |
6.65% 62/983 |
12.92% 390/991 |
4.85% 145/1011 |
| 2023 | -11.74% 390/952 |
1.53% 539/880 |
-11.86% 806/895 |
1.21% 54/915 |
-2.55% 277/952 |
| 2022 | -11.25% 100/867 |
-10.85% 127/773 |
9.77% 278/806 |
-15.54% 594/845 |
7.39% 128/867 |
| 2021 | - 349/740 |
0.62% 126/580 |
6.35% 442/659 |
-5.71% 376/704 |
-0.90% 478/740 |
| 2020 | 37.34% 317/554 |
-6.68% 333/419 |
15.81% 337/466 |
14.15% 160/517 |
11.33% 319/554 |
| 2019 | 39.85% 222/410 |
24.54% 736/1149 |
0.70% 267/1231 |
2.42% 268/390 |
8.88% 200/410 |
| 2018 | -21.75% 101/349 |
- - |
- - |
- - |
-12.78% 703/1080 |
| 2017 | 14.94% 107/285 |
- - |
- - |
- - |
- - |
| 2016 | -22.48% 126/205 |
- - |
- - |
- - |
- - |
| 2015 | 55.13% 17/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 景顺长城优质成长股票A VS. 东吴新产业精选股票A(580008) |